Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Clelia Zampaglione
Observed name:
C. Zampaglione
Institutions:
University of Pavia,
Policlinico San Matteo Fondazione
Observed institutions:
University of Pavia,
Policlinico San Matteo Fondazione
OpenAlex ID:
A5116073781
Anifrolumab Therapy in Dermatomyositis: New Insights From Refractory Patients
2025
·
Linda Carli
, Lorenzo Cavagna
, et al.
·
The Journal of Rheumatology
·
3
Tender joints in early autoantibody-negative rheumatoid arthritis: Should they be included in the scoring of joint involvement of the 2010 ACR/EULAR classification criteria?
2025
·
Ludovico De Stefano
, Emanuele Bozzalla Cassione
, et al.
·
Seminars in Arthritis and Rheumatism
·
2
Frequency and predictors of disease progression in contemporary ACPA-negative undifferentiated arthritis in a treated-to-target early arthritis clinic
2026
·
Ludovico De Stefano
, Elena Manna
, et al.
·
RMD Open
Real-world therapeutic strategies in active adult-onset Still’s disease: clinical insights from the GIRRCS-AOSD study group
2026
·
Piero Ruscitti
, Daniela Iacono
, et al.
·
Frontiers in Immunology
PDF
LBA:01:11 Proteinuria in a patient with HIV and systemic lupus erythematosus (SLE): a diagnostic dilemma
2026
·
Aurora Torlasco
, Francesca Bottazzi
, et al.
·
Lupus Science & Medicine
PDF
Pos0159 Positivity for Antinuclear Antibodies in Seronegative Early Rheumatoid Arthritis Identifies a Subgroup of Patients With Different Clinical Features and Better Response to Conventional Synthetic Disease Modifying Anti-rheumatic Drugs
2025
·
C. Zampaglione
, L. De Stefano
, et al.
·
Annals of the Rheumatic Diseases
Show more works
View as search
Works count:
6
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type